Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

HKG:0874 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14,511	18,273	21,309	22,500	22,377	19,470
Short-Term Investments	4,030	4,446	729.16	2,117	-	50
Trading Asset Securities	-	-	4	56.87	-	4
Cash & Short-Term Investments	18,541	22,719	22,042	24,673	22,377	19,524
Cash Growth	-6.16%	3.07%	-10.66%	10.26%	14.61%	5.47%
Accounts Receivable	22,717	19,456	19,598	19,168	17,211	15,689
Other Receivables	1,278	993.65	882.35	920.51	1,276	765.71
Receivables	23,996	20,449	20,480	20,088	18,486	16,455
Inventory	10,823	12,812	11,507	10,672	10,438	9,765
Other Current Assets	2,314	1,782	1,955	1,631	1,510	1,653
Total Current Assets	55,673	57,762	55,984	57,064	52,811	47,397
Property, Plant & Equipment	7,951	7,939	7,516	6,570	5,684	5,101
Long-Term Investments	10,646	10,146	9,452	5,897	2,891	2,751
Goodwill	834.09	830.85	829.47	829.47	829.47	825.57
Other Intangible Assets	2,827	2,829	2,886	2,585	2,582	2,444
Long-Term Deferred Tax Assets	1,219	1,210	1,164	865.34	794.23	751.72
Long-Term Deferred Charges	384.08	558.49	499.77	407.47	143.05	118.04
Other Long-Term Assets	514.39	407.77	256.22	446.54	382.46	372.43
Total Assets	80,048	81,684	78,587	74,665	66,118	59,760
Accounts Payable	16,411	16,320	15,686	14,961	14,733	14,159
Accrued Expenses	831.41	3,673	3,651	3,484	3,478	2,888
Short-Term Debt	9,005	9,123	7,799	9,146	8,428	8,266
Current Portion of Long-Term Debt	2,973	1,332	36.45	498.58	30.03	-
Current Portion of Leases	-	190.57	213.38	208.15	215.77	236.11
Current Income Taxes Payable	516.48	118.4	249.26	237	143.41	238.38
Current Unearned Revenue	1,174	5,072	5,430	5,644	2,740	1,249
Other Current Liabilities	5,198	3,088	3,170	3,216	2,485	2,207
Total Current Liabilities	36,109	38,916	36,235	37,395	32,254	29,243
Long-Term Debt	2,098	2,806	3,324	1,639	752.81	497.55
Long-Term Leases	443.55	445.72	578.19	545.84	497.7	561.82
Long-Term Unearned Revenue	1,015	1,002	1,001	930.93	826.86	784.07
Long-Term Deferred Tax Liabilities	625.15	625.56	639.53	394.59	331.73	286.36
Other Long-Term Liabilities	118.29	119.31	130.6	121.45	127.87	181.45
Total Liabilities	40,409	43,914	41,909	41,027	34,791	31,555
Common Stock	1,626	1,626	1,626	1,626	1,626	1,626
Additional Paid-In Capital	10,114	10,114	10,106	10,106	9,957	9,885
Retained Earnings	26,000	24,179	23,212	20,347	17,497	14,652
Comprehensive Income & Other	-20.64	-13.84	-24.34	-12.9	-17.48	-17.67
Total Common Equity	37,719	35,905	34,919	32,065	29,062	26,145
Minority Interest	1,920	1,865	1,759	1,573	2,264	2,060
Shareholders' Equity	39,639	37,770	36,678	33,638	31,327	28,205
Total Liabilities & Equity	80,048	81,684	78,587	74,665	66,118	59,760
Total Debt	14,520	13,897	11,951	12,038	9,924	9,561
Net Cash (Debt)	4,021	8,823	10,091	12,635	12,453	9,963
Net Cash Growth	-32.47%	-12.57%	-20.14%	1.47%	24.99%	-16.00%
Net Cash Per Share	2.47	5.43	6.21	7.77	7.66	6.13
Filing Date Shares Outstanding	1,626	1,626	1,626	1,626	1,626	1,626
Total Common Shares Outstanding	1,626	1,626	1,626	1,626	1,626	1,626
Working Capital	19,564	18,847	19,748	19,669	20,557	18,153
Book Value Per Share	23.20	22.08	21.48	19.72	17.88	16.08
Tangible Book Value	34,058	32,245	31,203	28,651	25,650	22,876
Tangible Book Value Per Share	20.95	19.83	19.19	17.62	15.78	14.07
Buildings	-	5,213	4,328	3,630	3,317	3,105
Machinery	-	5,106	4,416	4,025	3,582	3,103
Construction In Progress	-	1,846	2,405	2,108	1,564	1,276

Source: S&P Global Market Intelligence. Standard template. Financial Sources.